Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Jatrosom
2. Parnate
3. Sulfate, Tranylcypromine
4. Trans 2 Phenylcyclopropylamine
5. Trans-2-phenylcyclopropylamine
6. Transamine
7. Tranylcypromine
8. Tranylcypromine Sulfate
1. Tranylcypromine Sulfate
2. 13492-01-8
3. Tranylcypromine Sulfate (usp)
4. Chebi:9653
5. D00826
Molecular Weight | 364.5 g/mol |
---|---|
Molecular Formula | C18H24N2O4S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 2 |
Exact Mass | 364.14567842 g/mol |
Monoisotopic Mass | 364.14567842 g/mol |
Topological Polar Surface Area | 135 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 197 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
Antidepressive Agents
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)
Monoamine Oxidase Inhibitors
A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) (See all compounds classified as Monoamine Oxidase Inhibitors.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
18
PharmaCompass offers a list of Tranylcypromine Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tranylcypromine Sulfate manufacturer or Tranylcypromine Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tranylcypromine Sulfate manufacturer or Tranylcypromine Sulfate supplier.
PharmaCompass also assists you with knowing the Tranylcypromine Sulfate API Price utilized in the formulation of products. Tranylcypromine Sulfate API Price is not always fixed or binding as the Tranylcypromine Sulfate Price is obtained through a variety of data sources. The Tranylcypromine Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Jatrosom manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Jatrosom, including repackagers and relabelers. The FDA regulates Jatrosom manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Jatrosom API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Jatrosom manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Jatrosom supplier is an individual or a company that provides Jatrosom active pharmaceutical ingredient (API) or Jatrosom finished formulations upon request. The Jatrosom suppliers may include Jatrosom API manufacturers, exporters, distributors and traders.
click here to find a list of Jatrosom suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Jatrosom DMF (Drug Master File) is a document detailing the whole manufacturing process of Jatrosom active pharmaceutical ingredient (API) in detail. Different forms of Jatrosom DMFs exist exist since differing nations have different regulations, such as Jatrosom USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Jatrosom DMF submitted to regulatory agencies in the US is known as a USDMF. Jatrosom USDMF includes data on Jatrosom's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Jatrosom USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Jatrosom suppliers with USDMF on PharmaCompass.
A Jatrosom written confirmation (Jatrosom WC) is an official document issued by a regulatory agency to a Jatrosom manufacturer, verifying that the manufacturing facility of a Jatrosom active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Jatrosom APIs or Jatrosom finished pharmaceutical products to another nation, regulatory agencies frequently require a Jatrosom WC (written confirmation) as part of the regulatory process.
click here to find a list of Jatrosom suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Jatrosom as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Jatrosom API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Jatrosom as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Jatrosom and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Jatrosom NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Jatrosom suppliers with NDC on PharmaCompass.
Jatrosom Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Jatrosom GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Jatrosom GMP manufacturer or Jatrosom GMP API supplier for your needs.
A Jatrosom CoA (Certificate of Analysis) is a formal document that attests to Jatrosom's compliance with Jatrosom specifications and serves as a tool for batch-level quality control.
Jatrosom CoA mostly includes findings from lab analyses of a specific batch. For each Jatrosom CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Jatrosom may be tested according to a variety of international standards, such as European Pharmacopoeia (Jatrosom EP), Jatrosom JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Jatrosom USP).